A vendor working after the Nasdaq opening bell ceremony on April 18, 2019 in New York City.
Kena Betancur | Getty Concepts
Check out the companies making headlines after the bell on Monday:
Zoom Video – Shares of the video communications callers popped 8.5% on the back of better-than-expected fiscal fourth-quarter results. Zoom earned $1.22 per share on revenue of $882 million. Analysts voted by Refinitiv expected a profit of 79 cents per share on revenue of $812 million. That revenue figure impersonates a 369% surge on a year-over-year basis. Zoom also expects revenue to surge by 175% in the fiscal first dwelling-place and by 42% for the full fiscal year.
Roku – Roku’s stock jumped 2.8% on the news that the company is set to buy Nielsen’s video advertising business. “Combining Nielsen’s AVA technology with Roku’s innovative ad tech and scale last wishes as enable us to deliver the benefits of TV streaming advertising to traditional TV,” Louqman Parampath, Roku’s vice president of product running, said in a statement.
Novavax – The vaccine developer’s stock slid 4.2% after the company reported weaker-than-expected fourth-quarter culminates. Novavax lost $2.70 per share on revenue of $279.7 million. Analysts polled by Refinitv expected a loss per part of $1.49 on revenue of $304.9 million. CEO Stanley Erck told CNBC the company expects government clearance for its Covid-19 vaccine as original as May.
Inovio Pharmaceuticals – Inovio shares slid more than 6% after the company released its latest every ninety days figures. The company lost 14 cents per share, while analysts polled by FactSet expected a loss of 22 cents per division. Additionally, Inovio released Phase 3 trial results for a drug aimed at treating HPV.